Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors

NCT00722228 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT00722228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00722228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 31, 2008
Completion date
January 31, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, colorectal cancer, gastric cancer, kidney cancer, lung cancer, melanoma, ovarian cancer